- cafead Aug 14, 2024 at 11:32: AM
via Britain's health regulator said on Wednesday it has approved Japan-based Astellas Pharma's (4503.T), opens new tab therapy to treat a type of gastric cancer.
The monoclonal antibody, which can attach itself to certain cancer cells and destroy them, was approved in combination with a standard chemotherapy for adults with cancer in the stomach or the junction where the oesophagus joins the stomach.
article source
The monoclonal antibody, which can attach itself to certain cancer cells and destroy them, was approved in combination with a standard chemotherapy for adults with cancer in the stomach or the junction where the oesophagus joins the stomach.
article source